31 – 40 of 142
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
Mechanisms underlying cortical resonant states: implications for levodopa-induced dyskinesia
(
- Contribution to journal › Article
-
Mark
Animal Models of Parkinson's Disease: Limits and Relevance to Neuroprotection Studies
(
- Contribution to journal › Scientific review
- 2012
-
Mark
Neuregulin-1 receptor tyrosine kinase ErbB4 is upregulated in midbrain dopaminergic neurons in Parkinson disease
(
- Contribution to journal › Article
-
Mark
Impact of intravenous immunoglobulin on the dopaminergic system and immune response in the acute MPTP mouse model of Parkinson's disease
(
- Contribution to journal › Article
- 2011
-
Mark
Signs of Degeneration in 12-22-Year Old Grafts of Mesencephalic Dopamine Neurons in Patients with Parkinson's Disease
(
- Contribution to journal › Article
-
Mark
Systemic administration of Neuregulin-1ß(1) protects dopaminergic neurons in a mouse model of Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
The role of the MYD88-dependent pathway in MPTP-induced brain dopaminergic degeneration
(
- Contribution to journal › Article
-
Mark
The critical role of the MyD88-dependent pathway in non-CNS MPTP-mediated toxicity
(
- Contribution to journal › Article
- 2010
-
Mark
Neural grafting in Parkinson's disease: unraveling the mechanisms underlying graft-induced dyskinesia
(
- Contribution to journal › Scientific review
-
Mark
Modeling pathophysiological aspects of Parkinson’s disease: Manipulating DA handling and alpha-synuclein expression in the nigrostriatal pathway using viral vectors
(
- Thesis › Doctoral thesis (compilation)